| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
15,392
|
17,692
|
19,767
|
20,288
| | Cost of Revenue | 8,703 | 10,056 | 11,170 | 11,099 | | |
Gross Profit
|
6,689
|
7,636
|
8,597
|
9,189
| |
|
Operating Expenses |
|
Research Development | 1,847 | 1,733 | 1,730 | 1,692 |
|
Selling General and Administrative | 6,861 | 6,675 | 6,579 | 7,094 |
|
Non Recurring | 57 | 296 | 233 | 95 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(2,154)
|
(1,893)
|
(4,945)
|
308
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (76) | (821) | (4,995) | 6 |
|
Earnings Before Interest And Taxes | (2,152) | (1,889) | (4,940) | 314 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (2,152) | (1,889) | (4,940) | 314 |
|
Income Tax Expense | 16 | 106 |
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (2,168) | (1,995) | (4,940) | 314 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(2,168)
|
(1,995)
|
(4,940)
|
314
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(2,168)
|
(1,995)
|
(4,940)
|
314
|
|
0.80%